US 10479830
Anti eotaxin-2 antibodies that recognize additional CCR3-binding chemokines
granted A61KA61K2039/505A61K2039/545
Quick answer
US patent 10479830 (Anti eotaxin-2 antibodies that recognize additional CCR3-binding chemokines) held by CHEMOMAB LTD. expires Mon Nov 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CHEMOMAB LTD.
- Grant date
- Tue Nov 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K2039/505, A61K2039/545, A61P, A61P1/10